Brief: Intelgenx Says Its Site Obtained Amended Drug Establishment License For Manufacturing Activities
18/12/2017 13:04
Dec 18 (Reuters) - Intelgenx Technologies Corp IGX.V :
* INTELGENX-AFTER GOOD MANUFACTURING PRACTICES INSPECTION BY
HEALTH CANADA,SITE OBTAINED AMENDED DRUG ESTABLISHMENT LICENSE
FOR MANUFACTURING ACTIVITIES
Source text for Eikon: ID:nMKWFks32a
Further company coverage: IGX.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA